Recent advances in cannabinoid receptor agonists and antagonists

Expert Opinion on Therapeutic Patents

Volumn 10, Issue 10, 2000, Pages 1529-1538

  Goya, P ^a   Jagerovic, N ^a  

^a INSTITUTO DE QUÍMICA MÉDICA   (Spain)

Author keywords

Anandamide; Cannabinoid receptor agonists; Cannabinoid receptor antagonists; Cannabinoids; CB1; CB2

Indexed keywords

2 ARACHIDONYL GLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 [4 (1,1 DIMETHYLHEPTYL) 2,6 DIMETHOXYPHENYL] 6,6 DIMETHYLBICYCLO[3.1.1]HEPT 2 EN 2 YLMETHANOL; 6 BROMOETHYLENE TETRAHYDRO 3 (NAPHTHALEN 1 YL) 2H PYRAN 2 ONE; AJULEMIC ACID; AM 411; AM 724; ANANDAMIDE; ARACHIDONYL 2' CHLOROETHYLAMIDE; ARACHIDONYL CYCLOPROPYLAMIDE; CANNABIDIOL; CANNABINOID; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; DELTA8 TETRAHYDROCANNABINOL; DEXANABINOL; DRONABINOL; HU 310; IMMUNOMODULATING AGENT; LEVONANTRADOL; NABILONE; NAPHTHYLOXYPHENYLBUTANESULPHONAMIDE; PHENYLCYCLOHEXANOL; PRAVADOLINE; QUINOLINE; QUINOLINE DERIVATIVE; RIMONABANT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ANTIEMETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; CLINICAL TRIAL; DEGENERATIVE DISEASE; DRUG BIOAVAILABILITY; DRUG CONFORMATION; DRUG DEPENDENCE; DRUG FORMULATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; GLAUCOMA; GLIOBLASTOMA; HUMAN; HUMAN CELL; MEDICAL LITERATURE; MOUSE; MUSCLE SPASM; NAUSEA; NEUROPROTECTION; NONHUMAN; PATENT; RAT; RECEPTOR AFFINITY; REVIEW; RHEUMATOID ARTHRITIS; STRUCTURE ACTIVITY RELATION; TREMOR;

EID: 0033815067     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.10.10.1529     Document Type: Review

References (40)

1. Determination and characterization of a cannabinoid receptor in rat brain
2. Molecular characterization of a peripheral receptor for cannabinoids
3. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
4. Identification of endogenous 2-monoglyceride present in canine gut that binds to cannabinoid receptors
5. Cannabinoids control spasticity and tremor in a multiple sclerosis model
6. Cannabinoids as potential new analgesics
7. Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2
8. Endocannabinoids and vascular function
9. Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
10. Cannabinoid receptor agonists and antagonists
11. Pharmacology of cannabinoid receptor agonists and antagonists
12. The development of cannabinoid antagonists
13. The endocannabinoid system as a target for therapeutic drugs
14. Review: Endocannabinoids
15. Discovery and characterization of endogenous cannabinoids
16. 1)
17. Anandamide: An endogenous activator of the vanilloid receptor
18. Structure-activity relationships of anandamide, an endogenous cannabinoid ligand
19. Molecular characterisation of an enzyme that degrades neuromodulatory fatty acid amides
20. Functional role of high affinity anadamide transport as revealed by selective inhibition
21. 2 cannabinoid receptors and metabolic stability
22. Unique analogues of anandamide: Arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas
23. Exploration of biologically relevant conformations of anandamide: 2-arachidonylglycerol and their analogues using conformational memories
24. Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis
25. Towards cannabinoid drugs-revisited
26. 8-THC analogues: Relationship of side-chain conformation to cannabinoid receptor affinity and pharmacological potency
27. 8-tetrahydrocannabinol
28. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists and antagonists
29. 8-tetrahydrocannabinol series
30. Synthesis and analgesic activity of non-classical bicyclic cannabinoid analogues
31. 2, a peripheral cannabinoid receptor
32. 1',1'-Dimethylheptyl-Δ-8-tetrahydrocannabinol-11-oic acid: A novel, orally effective cannabinoid with analgesic and anti-inflammatory properties
33. SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist
34. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists
35. Comparative receptor binding analyses of cannabinoid agonists and antagonists
36. 3-Alkyl-(5,5'-diphenyl)imidazolidine diones as new cannabinoid receptor ligands
37. Cannabimimetic indoles, pyrroles and indenes
38. High-resolution NMR and computer modeling studies of the cannabimimetic aminoalkylindole prototype WIN-55212-2
39. 2
40. Cannabis and cannabinoids: Pharmacology and rationale for clinical use